title: [Severe epistaxis secondary to ticlopidine. Report of 3 cases].
abstract: Ticlopidine (Ticlid@) is a platelet aggregation inhibitor that can produce bleeding or severe hemorrhage as a side-effect. The cases of three patients on previous treatment with that drug that required admission in our hospital because of recurrent epistaxis are reported. We have analysed their personal antecedents, complementary explorations, type of nasal packing used, clinical evolution and stay.
authors.affiliation: Complejo Hospitalario Infanta Cristina, Badajoz. vicentepinorivero@terra.com
authors.forename: V
authors.initials: V
authors.lastname: Pino Rivero
authors.forename: M
authors.initials: M
authors.lastname: Marcos García
authors.forename: G
authors.initials: G
authors.lastname: Trinidad Ruíz
authors.forename: T
authors.initials: T
authors.lastname: Keituqwa Yáñez
authors.forename: G
authors.initials: G
authors.lastname: Pardo Romero
authors.forename: A
authors.initials: A
authors.lastname: González Palomino
authors.forename: A
authors.initials: A
authors.lastname: Blasco Huelva
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004844:Epistaxis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D013630:Tampons, Surgical; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine
vernacular_title: Epístaxis intensa secundaria a ticlopidina. Presentación de 3 casos.